Actively Recruiting
Yoga for Treatment of Overactive Bladder in Pediatric Patients
Led by Duke University · Updated on 2026-01-30
40
Participants Needed
1
Research Sites
52 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this pilot study is to assess the impact of yoga as a treatment modality in pediatric patients age 8-18 diagnosed with idiopathic overactive bladder as measured by validated questionnaires and urinary biomarkers. The main question it aims to answer is: Does yoga help improve overactive bladder symptoms in this patient population? Participants will take part in a weekly yoga session for a total of 6 weeks with validated questionnaires and urinary samples for biomarkers to be completed at the beginning, middle and end of the study. This study will follow a cross-over study design and patients will receive standard of care while not in the active treatment arm.
CONDITIONS
Official Title
Yoga for Treatment of Overactive Bladder in Pediatric Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 8-18 years of age
- History of non-neurogenic overactive bladder or detrusor overactivity and/or urinary incontinence
- Obtained legally effective informed consent and HIPPA authorization from participant or parent/legal guardian
- Minor participant willing and able to provide assent as applicable
- Vancouver Dysfunctional Elimination Syndrome score of 11 or higher and a positive modified bother score within 30 days of consent
You will not qualify if you...
- Known or untreated anatomical abnormality of lower urinary tract
- Known neurogenic bladder (e.g., spina bifida, spinal cord injury, tethered cord)
- Nerve damage impacting pelvic floor function
- History of bladder chemodenervation (e.g., botulinum toxin injection)
- Active, untreated urinary tract infection at enrollment (treated UTI allowed)
- Current or previous pregnancy at screening or planned pregnancy during study for females of childbearing potential
- Any condition judged by investigator to prevent safe participation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Duke University Hospital
Durham, North Carolina, United States, 27701
Actively Recruiting
Research Team
R
Rafael Tua-Caraccia, MD
CONTACT
J
Jonathan Routh, MD, MPH
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
NON_RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here